Cargando…
CAR Selectively Enhances the Pulmonary Vasodilatory Effect of Fasudil in a Microsphere Model of Pulmonary Hypertension
BACKGROUND: Despite the approval of several medications for pulmonary hypertension, morbidity and mortality are unacceptably high. Systemic hypotension may limit the use of pulmonary hypertension medications. OBJECTIVES: This study aimed to assess whether the homing peptide CAR (CARSKNKDC) improves...
Autores principales: | Rothman, Abraham, Restrepo, Humberto, Evans, William N., Sarukhanov, Valeri, Mann, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351346/ https://www.ncbi.nlm.nih.gov/pubmed/37916136 http://dx.doi.org/10.2174/18743064-v17-e230404-2022-19 |
Ejemplares similares
-
Challenges in the development of chronic pulmonary hypertension models in large animals
por: Rothman, Abraham, et al.
Publicado: (2017) -
Vascular histomolecular analysis by sequential endoarterial biopsy in a shunt model of pulmonary hypertension
por: Rothman, Abraham, et al.
Publicado: (2013) -
Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy
por: Rothman, Abraham, et al.
Publicado: (2017) -
Hemodynamic and clinical effects of selexipag in children with pulmonary hypertension
por: Rothman, Abraham, et al.
Publicado: (2020) -
Peptide-Coated Liposomal Fasudil Enhances Site Specific
Vasodilation in Pulmonary Arterial Hypertension
por: Nahar, Kamrun, et al.
Publicado: (2014)